Results 241 to 250 of about 1,048,296 (327)

Industrial Dynamics and Business Strategies in the Emergence of Agricultural Biological Inputs

Business Strategy and the Environment, EarlyView.
ABSTRACT Biological products present a sustainable alternative to synthetic agricultural inputs, yet the industrial dynamics triggered by these solutions remain unexplored. This study examines the strategic responses of dominant agricultural input firms to the rise of biological solutions. Through qualitative textual analysis of press releases, company
Pablo Mac Clay, Guillermo Bort, Roberto Feeney, Jorge Sellare   +3 more
wiley   +1 more source

Process intensification of the baculovirus expression vector system using a perfusion process with a low multiplicity of infection at high cell concentrations

Biotechnology Progress, EarlyView.
Abstract The emergence of new viruses and the spread of existing pathogens necessitate efficient vaccine production methods. The baculovirus expression vector system (BEVS) is an efficient and scalable system for subunit and virus‐like particle vaccine production and gene therapy vectors.
Jort J. Altenburg, Brenda E. Juarez‐Garza, Jelle van Keimpema, Linda van Oosten, Gorben P. Pijlman, Monique M. van Oers, René H. Wijffels, Dirk E. Martens   +7 more
wiley   +1 more source

Pneumococcal serotypes and their association with death risk in invasive pneumococcal disease: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Darkwah S, Somda NS, Mahazu S, Donkor ES.   +3 more
europepmc   +1 more source

Immunogenicity of DTaP-IPV-Hib and MenC vaccines in the UK when administered with a 13-valent pneumococcal conjugate vaccine

, 2008
Baker, S., Daniels, E., Dymond, S., Faust, S.N., Finn, A., Galiza, E., Gruber, W., Heath, P.T., John, T., Klinger, C., Layton, H., Pestridge, S., Pollard, A., Scott, D., Snape, M., Tansey, S.   +15 more
core  

Interaction of meningococcal conjugate vaccines with other conjugate or diphtheria-tetanus containing vaccines

Journal of Travel Medicine, 2018
Robert Booy, Robert Booy, Mohamad Tashani, Mohamad Tashani, Al-Mamoon Badahdah, Al-Mamoon Badahdah, Al-Mamoon Badahdah, Ameneh Khatami, Harunor Rashid, Harunor Rashid   +9 more
openaire   +2 more sources

A recurrent neural network for soft sensor development using CHO stable pools in fed‐batch process for SARS‐CoV‐2 spike protein production as a vaccine antigen

Biotechnology Progress, EarlyView.
Abstract Fed‐batch recombinant therapeutic protein (RTP) production processes utilizing Chinese Hamster Ovary (CHO) cells can take a long period of time (>10 days). Within this period, not all critical features may be measured routinely, and in fact, some are only measured once the process is terminated, complicating decision making.
Sebastian‐Juan Reyes, Robert Voyer, Yves Durocher, Olivier Henry, Phuong Lan Pham   +4 more
wiley   +1 more source

Multimeric, multivalent fusion carrier proteins for site-selective glycoconjugate vaccines simultaneously targeting <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>. [PDF]

Chem Sci
Sorieul C, Mikladal B, Wu DY, Brogioni B, Giovani C, Adamo G, Romagnoli G, Margarit Y Ros I, Codée J, Romano MR, Carboni F, Adamo R.   +11 more
europepmc   +1 more source

Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway

Cancer Communications, EarlyView.
Abstract Background Radiotherapy (RT) is a key treatment modality in cancer therapy, utilizing high‐energy radiation to directly kill tumor cells. Recent research has increasingly highlighted RT's potential to indirectly enhance antitumor immunity. However, this immune activation alone often fails to generate sustained systemic antitumor responses.
Xuejiao Han, Yuan Cheng, Dandan Wan, Aqu Alu, Ziqi Zhang, Zhenfei Bi, Manni Wang, Yan Tang, Weiqi Hong, Siyuan Chen, Li Chen, Yuquan Wei   +11 more
wiley   +1 more source

Vaccine Knowledge, Attitude, and Hesitancy Among Healthcare Professionals in the Kingdom of Bahrain: A Cross-Sectional Survey. [PDF]

Cureus
AlMusawi S, Radhi M, Mani Prabu Kumar T, AlSalman E, Khaleel M, Altaitoon K, Majeed F, AlMusawi Z.   +7 more
europepmc   +1 more source

Combating cancer immunotherapy resistance: a nano‐medicine perspective

Cancer Communications, EarlyView.
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong, Xintong Xie, Juan Wu, Xiangyu Wang, Wenxiang Zhang, Shuowen Wang, Daria Valerievna Abbasova, Yi Fang, Hongnan Jiang, Jidong Gao, Jing Wang   +10 more
wiley   +1 more source